Over the past decades, researchers have reported several mechanisms for doxorubicin
(DOX)-induced cardiomyopathy, including oxidative stress, inflammation, and apoptosis …

Mesenchymoangioblast (MB) is the earliest precursor for endothelial and mesenchymal
cells originating from APLNR+ PDGFRα+ KDR+ mesoderm in human pluripotent stem cell …

Abuse of the hallucinogenic drug ketamine promotes the development of lower urinary tract
symptoms that resemble interstitial cystitis. The pathophysiology of ketamine-induced cystitis …

The anthracycline doxorubicin (Dox) is widely used in oncology, but it may cause a
cardiomyopathy with bleak prognosis that cannot be effectively prevented. The secretome of …

Myocardial injury is a major pathological factor that causes death in patients with heart
diseases. In recent years, mesenchymal stromal cells (MSCs) have been generally used in …

Most chronic diseases involving inflammation have a fibrotic component that involves
remodeling and excess accumulation of extracellular matrix components. Left unchecked …

The cardiac protection of mesenchymal stem cell (MSC) transplantation for myocardial
infarction (MI) is largely hampered by low cell survival. Haem oxygenase 1 (HO‐1) plays a …

The clinical application of doxorubicin (Dox) is limited by its adverse effect of cardiotoxicity.
Previous studies have suggested the cardioprotective effect of brain‐derived neurotrophic …

Doxorubicin (DOXO), an anthracycline antibiotic, is a commonly used anticancer drug.
Despite its widespread usage, the therapeutic effects of DOXO are limited by its …

Mesenchymal stem cells (MSCs) have shown beneficial effects in the treatment of
abdominal aortic aneurysm (AAA). Nonetheless, the biological properties of adipose-derived …